Induction of antigen-specific effector-phase tolerance following vaccination against a previously ignored B-cell lymphoma (Q39631497)

13 September 2017

title

Induction of antigen-specific effector-phase tolerance following vaccination against a previously ignored B-cell lymphoma (English)

1 reference

13 September 2017

5

1 reference

13 September 2017

2

0 references

Mireille H. Lahoud

object named as

Mireille H Lahoud

series ordinal

3

0 references

David C Huang

object named as

David C Huang

series ordinal

4

0 references

author name string

Sandro Prato

series ordinal

1

1 reference

13 September 2017

publication date

16 November 2010

1 reference

Immunology & Cell Biology

13 September 2017

published in

1 reference

13 September 2017

volume

89

1 reference

13 September 2017

issue

5

1 reference

13 September 2017

page(s)

595-603

1 reference

https://scigraph.springernature.com/pub.10.1038/icb.2010.131

13 September 2017

exact match

0 references

cites work

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Does the immune system see tumors as foreign or self?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Cellular and molecular mechanisms of tumor-induced T-cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Immune surveillance against a solid tumor fails because of immunological ignorance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Ex vivo priming of CD4 T cells converts immunological tolerance into effective antitumor immunity in a murine model of acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

The cell biology of cross-presentation and the role of dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Use of tumour-responsive T cells as cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Cyclin D1-specific cytotoxic T lymphocytes are present in the repertoire of cancer patients: implications for cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

T cell receptor antagonist peptides induce positive selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Tissue destruction caused by cytotoxic T lymphocytes induces deletional tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

The structure of a mutant H–2 gene suggests that the generation of polymorphism in H–2 genes may occur by gene conversion-like events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

7 January 2021

Reversal of CD8+ T cell ignorance and induction of anti-tumor immunity by peptide-pulsed APC

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

7 January 2021

Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

7 January 2021

Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

7 January 2021

Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.131

7 January 2021

Identifiers

DOI

10.1038/ICB.2010.131

1 reference

Dimensions Publication ID

13 September 2017

1023118635

0 references

1 reference